Overview

Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment

Status:
Terminated
Trial end date:
2020-01-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of SPN-810 for the treatment of impulsive aggression (IA) in adolescents diagnosed with ADHD when taken in conjunction with standard ADHD treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Supernus Pharmaceuticals, Inc.